Biologic risk stratification of medulloblastoma: The real time is now

Journal of Clinical Oncology

Volumn 22, Issue 6, 2004, Pages 971-974

  Fisher, Paul Graham ^a   Burger, Peter C ^a   Eberhart, Charles G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

BRAIN STEM; BRAIN TUMOR; CANCER GRADING; CANCER SURVIVAL; CEREBELLUM TUMOR; CEREBROSPINAL FLUID; CLINICAL FEATURE; EDITORIAL; HISTOLOGY; HUMAN; HYDROCEPHALUS; MEDULLOBLASTOMA; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; WORLD HEALTH ORGANIZATION; CHILD; FEMALE; GENETICS; MALE; MORTALITY; NOTE; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SURVIVAL RATE;

CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 1842509920     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.12.939     Document Type: Editorial

References (40)

1. Strother DR, Pollack IF, Fisher PG, et al: Tumors of the central nervous system, in: Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 4). Philadelphia, PA, Lippincott Williams and Wilkins, 2002, pp 751-824
2. Giangaspero F, Bigner SH, Kleihues P, et al: Medulloblastoma, in: Kleihues P, Cavenee WK (eds): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System. Lyon, France, International Agency for Research on Cancer, 2000, pp 129-137
3. Gurney JG, Smith MA, Bunin GR. CNS and miscellaneous intracranial and intraspinal neoplasms, in: Ries LAG, Smith MA, Gurney JG, et al (eds): Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. NIH Pub. No. 99-4649. Bethesda, MD, National Cancer Institute, 1999, pp 51-63
4. Gajjar A, Hernan R, Kocak M, et al: Clinical, histopathological and molecular markers of prognosis: Toward a new disease risk stratification for medulloblastoma. J Clin Oncol 22: 984-993, 2004
5. Fernandez-Teijeiro A, Betensky RA, Sturla LM, et al: Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas. J Clin Oncol 22: 994-998, 2004
6. Tait DM, Thronton-Jones H, Bollom HJG, et al: Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26:464-469, 1990
7. Evans AE, Jenkin RDT, Sposto R, et al: The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72: 572-582, 1990
8. Krischer JP, Ragab AH, Kun L, et al: Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74:905-909, 1991
9. Packer RJ, Goldwein J, Nicholson HS, et al: Treatment of children with medulloblastoma with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group study. J Clin Oncol 17:2127-2136, 1999
10. Chang CH, Housepian EM, Herbert C: An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastoma. Radiology 93:1351-1359, 1969
11. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase II study. J Clin Oncol 17:832-845, 1999
12. Kortmann RD, Kuhl J, Timmerman B, et al: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46:269-279, 2000
13. McNeil DE, Cote TR, Clegg L, et al: Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: A SEER update. Med Pediatr Oncol 39:190-194, 2002
14. Chatty EM, Earle KM: Medulloblastoma: A report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer 28:977-983, 1971
15. Giangspero F, Rigobello L, Bodily M, et al: Large-cell medullobastomas: A distinct variant with highly aggressive behavior. Am J Surg Pathol 16:687-693, 1992
16. Eberhart CG, Kepner JL, Goldthwaite PT, et al: Histopathologic grading of medulloblastomas: A Pediatric Oncology Group study. Cancer 94:552-560, 2002
17. McManamy CS, Lamont JM, Taylor RE, et al: Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol 62:627-632, 2003
18. Herms J, Neidt I, Luscher B, et al: C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer 89:395-402, 2000
19. Grotzer MA, Hogarty MD, Janss AJ, et al: MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 7:2425-2433, 2001
20. Scheurlein WG, Schwabe GC, Joos S, et al: Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 16:2478-2485, 1998
21. Brown HG, Kepner JL, Perlman EJ, et al: "Large cell/anaplastic" medulloblastomas: A Pediatric Oncology Group study. J Neuropathol Exp Neurol 59:857-865, 2000
22. Leonard JR, Cai DX, Rivet DJ, et al: Large cell/anaplastic medulloblastomas and medullomyoblastomas: Clinicopathological and genetic features. J Neurosurg 95:82-88, 2001
23. Eberhart CG, Kratz JE, Schuster A, et al: Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas. Brain Pathol 12:36-44, 2002
24. Bigner SH, Mark J, Friedman HS, et al: Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 30:91-101, 1988
25. Biegel JA, Janss AJ, Raffel C, et al: Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system. Clin Cancer Res 3:473-478, 1997
26. Rood BR, Zhang H, Weitman DM, et al: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res 62:3794-3797, 2002
27. Waha A, Waha A, Koch A, et al: Epigenetic silencing of the HIC-1 gene in human medulloblastoma. J Neuropathol Exp Neurol 62:1192-1201, 2003
28. Grotzer MA, Janss AJ, Fung KN, et al: TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18:1027-1035, 2000
29. Kim JYH, Sutton ME, Lu DJ, et al: Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res 59:711-719, 1999
30. Pomeroy SL, Tamayo P, Gaasenbeek M, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002
31. MacDonald TJ, Brown KM, LaFleur B, et al: Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet 29:143-152, 2001
32. Gilbertson R, Wickramasinghe C, Hernan R, et al: Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer 85:705-712, 2001
33. Eberhart CG, Burger PC: Anaplasia and grading in medulloblastoma. Brain Pathol 13:376-385, 2003
34. Weil MD, Lamborn K, Edwards MSB, et al: Influence of a child's sex on medulloblastoma. JAMA 279:1474-1476, 1998
35. Roberts RO, Lynch CF, Jones MP, et al: Medulloblastoma: A population-based study of 532 cases. J Neuropathol Exp Neurol 50:134-144, 1991
36. Gajjar AJ, Heidemann RL, Douglass EC, et al: Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 11:2211-2217, 1993
37. Zerbini C, Gelber RD, Weinberg D, et al: Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 11:616-622, 1993
38. Haslam RHA, Lamborn KR, Becker LE, et al: Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma. J Pediatr Hematol Oncol 20:520-527, 1998
39. Grotzer MA, Geoerger B, Janss AJ, et al: Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system. Med Pediatr Oncol 36:268-273, 2001
40. 28k: A marker of recurrence for medulloblastomas. Cancer 95:410-419, 2002